Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Surgery on a 68-year-old woman with an ovarian tumor led to reduced hirsutism and normal testosterone levels.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Most women with excessive hair growth have a hormonal cause.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

People with severe acne tend to have higher levels of betatrophin.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

High BMI worsens hair growth in women with PCOS.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The document concludes that an inherited nail condition often improves on its own, and spironolactone effectively treats acne in women.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.